Genetic Polymorphisms of X-ray Repair Cross-Complementing Group 1 and Apurinic/Apyrimidinic Endonuclease-1 in Chronic Obstructive Pulmonary Disease
- 129 Downloads
Chronic obstructive pulmonary disease (COPD) is a heterogeneous collection of conditions characterized by irreversible expiratory airflow limitation. The disease is interspersed with exacerbations; periods of acute symptomatic, physiological, and functional deterioration. The present study was designed to investigate the role of X-ray cross-complementing group 1 (XRCC1) and apurinic/apyrimidinic endonuclease 1 (APE1) polymorphisms and the risk of COPD. Blood samples from 354 unrelated subject (age range 18–60 years; 156 with COPD, 198 healthy controls) were collected. Genomic DNA was isolated and genotyped for XRCC1 Arg399Gln and APE1 Asp148Glu using a confronting two pair primers polymerase chain reaction. GA genotype of XRCC1 gene was found to be predominant in the COPD group compared to controls with 1.86-fold increased risk for COPD (OR 1.86, 95 % CI 1.20–2.88, p = 0.0013). TG genotype of APE1 was found to be predominant in COPD group compared to controls with the difference being statistically significant (OR 1.68, 95 % CI 1.08–2.61, p = 0.0043). The GA haplotype was found to be predominant in COPD than controls with a 2.19-fold significant increase (OR 2.19, 95 % CI 1.46–3.28, p = 0.003). Polymorphism in XRCC1 and APE1 gene is associated with an increased risk of COPD.
KEY WORDSCOPD APE1 XRCC1 polymorphisms
The study was not supported by any intramural or extramural funds.
Compliance with ethical standards
Conflict of interest
The authors hereby declare no conflict of interest.
- 1.Vestbo, J. 2013. “definition and overview”. global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease. 1–7.Google Scholar
- 2.Vispe, S., T.M. Yung, J. Ritchot, H. Serizawa, and M.S. Satoh. 2000. A cellular defense pathway regulating transcription through poly (ADP-ribosyl) ation in response to DNA damage. Proceedings of the National Academy of Sciences of the United States of America 97: 9886–9891.CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Hang, B. 2010. Formation and repair of tobacco carcinogen-derived bulky DNA adducts. Journal of Nucleic Acids. 709521.Google Scholar
- 16.Krupa, R., and J. Blasiak. 2004. An association of polymorphism of DNA repairs genes XRCC1 and XRCC3 with colorectal cancer. Experimental & Clinical Cancer Research 23: 285–294.Google Scholar
- 22.Shen, M., R.J. Hung, P. Brennan, C. Malaveille, F. Donato, D. Placidiv, et al. 2003. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiology, Biomarkers and Prevention 12: 1234–1240.PubMedGoogle Scholar
- 23.Halliwell, B., and J.M. Gutteridge. 1999. Free radicals in biology and medicine, 3rd ed, 50–70. London: Oxford University Press.Google Scholar